Status:
COMPLETED
Pharmacokinetics and Metabolism Study in Healthy Male Participants
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Cancer
Eligibility:
MALE
18-50 years
Phase:
PHASE1
Brief Summary
Phase 1 Phamacokinetic and metabolism study of BMS-986205 in healthy males
Eligibility Criteria
Inclusion
- Body weight 75-95kg, BMI 18.0-32.0 kg/m\^2
- Refrain from sperm donation 110 days after dosing
Exclusion
- Current or recent gastrointestinal disease
- Any GI surgery that could impact drug absorption
- Active, known, or suspected autoimmune disease
- Other protocol defined inclusion/exclusion criteria could apply
Key Trial Info
Start Date :
July 19 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2017
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT03247283
Start Date
July 19 2017
End Date
October 15 2017
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Covance Clinical Research Unit, Inc.
Madison, Wisconsin, United States, 53704